ALEXIS GOODRIDGE: Open Payments
NPI 1205464617 · WALTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,172 in 60 payments from 11 companies in 2025. Trend: 2023 $743 · 2024 $1,038 · 2025 $1,172
Food & beverage: $1,172
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $371 |
| Vanda Pharmaceuticals Inc. | 10 | $291 |
| Otsuka America Pharmaceutical, Inc. | 10 | $223 |
| Axsome Therapeutics, Inc. | 4 | $75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $48 |
| Exact Sciences Corporation | 2 | $34 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
Products named: VRAYLAR, REXULTI, HETLIOZ, FANAPT, Auvelity, CAPLYTA, TRINTELLIX, The Cologuard Plus Collection Kit.
Industry payments across KY — which companies pay providers there.
